Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 13,650 | $38.27 | $522,385.50 |
DisclosureSEC source: 0001225208-12-010297 · doc4.xml · derivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,650 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Tax withholdingCommon Stock | 6,327 | $38.27 | $242,134.29 |
DisclosureSEC source: 0001225208-12-010297 · doc4.xml · nonDerivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,343.944 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 13,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010297 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,670.944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Exercise / conversionRSU - Leader Shares · Derivative | 15,000 | $38.27 | $574,050.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 7 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,700 | $38.27 | $447,759.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 6 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Tax withholdingCommon Stock | 6,896 | $38.27 | $263,909.92 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,829.149 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Tax withholdingCommon Stock | 4,253 | $38.27 | $162,762.31 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,725.149 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Exercise / conversionCommon Stock | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,978.149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,278.149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,475 | $38.27 | $439,148.25 |
DisclosureSEC source: 0001225208-12-010299 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,475 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Tax withholdingCommon Stock | 4,535 | $38.27 | $173,554.45 |
DisclosureSEC source: 0001225208-12-010299 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,034.917 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 11,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010299 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,569.917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 651.0417 | $38.40 | $25,000.00 |
DisclosureSEC source: 0001225208-12-008830 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,028.6097 Underlying: Common Stock · 651.0417 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
GOLDSTONE STEVEN FDirector
|
GrantPhantom Stock · Derivative | 716.1458 | $38.40 | $27,500.00 |
DisclosureSEC source: 0001225208-12-008831 · doc4.xml · derivative · entry 2 GOLDSTONE STEVEN F · CIK 0001210409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,353.8598 Underlying: Common Stock · 716.1458 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 944.0104 | $38.40 | $36,250.00 |
DisclosureSEC source: 0001225208-12-008832 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,214.0524 Underlying: Common Stock · 944.0104 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
KELLEY WILLAM NDirector
|
GrantPhantom Stock · Derivative | 748.6979 | $38.40 | $28,750.00 |
DisclosureSEC source: 0001225208-12-008833 · doc4.xml · derivative · entry 3 KELLEY WILLAM N · CIK 0001204361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,230.1349 Underlying: Common Stock · 748.6979 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 672.7344 | $38.40 | $25,833.00 |
DisclosureSEC source: 0001225208-12-008834 · doc4.xml · derivative · entry 4 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,050.5164 Underlying: Common Stock · 672.7344 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
TATLOCK ANNE MDirector
|
GrantPhantom Stock · Derivative | 748.6979 | $38.40 | $28,750.00 |
DisclosureSEC source: 0001225208-12-008835 · doc4.xml · derivative · entry 3 TATLOCK ANNE M · CIK 0001020567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,002.6379 Underlying: Common Stock · 748.6979 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 716.1458 | $38.40 | $27,500.00 |
DisclosureSEC source: 0001225208-12-008836 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,328.3468 Underlying: Common Stock · 716.1458 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 651.0417 | $38.40 | $25,000.00 |
DisclosureSEC source: 0001225208-12-008837 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,700.7397 Underlying: Common Stock · 651.0417 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantCommon Stock | 1,071 | $38.38 | $41,104.98 |
DisclosureSEC source: 0001225208-12-006218 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,267.238 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantCommon Stock | 4,268 | $38.38 | $163,805.84 |
DisclosureSEC source: 0001225208-12-006219 · doc4.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,171.487 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 21,228 | $38.38 | $814,730.64 |
DisclosureSEC source: 0001225208-12-006220 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,747.542 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantCommon Stock | 8,705 | $38.38 | $334,097.90 |
DisclosureSEC source: 0001225208-12-006221 · doc4.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,873.437 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantCommon Stock | 13,069 | $38.38 | $501,588.22 |
DisclosureSEC source: 0001225208-12-006222 · doc4.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,067.902 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantCommon Stock | 16,701 | $38.38 | $640,984.38 |
DisclosureSEC source: 0001225208-12-006223 · doc4.xml · nonDerivative · entry 1 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,705.9037 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantCommon Stock | 10,165 | $38.38 | $390,132.70 |
DisclosureSEC source: 0001225208-12-006224 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,315.669 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantCommon Stock | 8,709 | $38.38 | $334,251.42 |
DisclosureSEC source: 0001225208-12-006225 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,832.965 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantCommon Stock | 9,194 | $38.38 | $352,865.72 |
DisclosureSEC source: 0001225208-12-006226 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantCommon Stock | 9,656 | $38.38 | $370,597.28 |
DisclosureSEC source: 0001225208-12-006227 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,409.6674 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,192 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · derivative · entry 22 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,192 shares Expires 2013-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,175 | $0.00 Strike: $38.01 | $0.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · derivative · entry 21 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,175 shares Expires 2012-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 15,800 | $38.77 | $612,566.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 18 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,540 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 7,030 | $38.78 | $272,623.40 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 17 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,340 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 6,677 | $38.79 | $259,000.83 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 16 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,370 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 4,700 | $38.76 | $182,172.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 15 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,047 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 4,700 | $38.81 | $182,407.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 14 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,747 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 1,100 | $38.80 | $42,680.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 13 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,447 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 755 | $38.79 | $29,288.34 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 12 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,547 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 300 | $38.78 | $11,634.75 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 11 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,302 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 234 | $38.82 | $9,082.71 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 10 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,602 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 210 | $38.81 | $8,150.63 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 9 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,836 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 200 | $38.79 | $7,757.98 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 8 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,046 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 200 | $38.80 | $7,759.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 7 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,246 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 173 | $38.79 | $6,710.69 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 6 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,446 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 100 | $38.77 | $3,876.50 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,619 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 100 | $38.77 | $3,877.25 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 4 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,719 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 88 | $38.82 | $3,416.16 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,819 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionCommon Stock | 20,192 | $21.08 | $425,647.36 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionCommon Stock | 22,175 | $38.01 | $842,871.75 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.